Source: European Journal of Medicinal Chemistry. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARDOSO, H. S. et al. In vitro mutagenicity of anti-inflammatory parsalmide analogues PA7, PA10, and PA31 triggered by biotransformation into hydroxy derivatives. European Journal of Medicinal Chemistry, v. 41, n. 3, p. 408-416, 2006Tradução . . Disponível em: https://doi.org/10.1016/j.ejmech.2005.10.019. Acesso em: 15 out. 2024.APA
Cardoso, H. S., Bicalho, B., Genari, P., Santagada, V., Caliendo, G., Perissutti, E., et al. (2006). In vitro mutagenicity of anti-inflammatory parsalmide analogues PA7, PA10, and PA31 triggered by biotransformation into hydroxy derivatives. European Journal of Medicinal Chemistry, 41( 3), 408-416. doi:10.1016/j.ejmech.2005.10.019NLM
Cardoso HS, Bicalho B, Genari P, Santagada V, Caliendo G, Perissutti E, Donato JL, De Nucci G. In vitro mutagenicity of anti-inflammatory parsalmide analogues PA7, PA10, and PA31 triggered by biotransformation into hydroxy derivatives [Internet]. European Journal of Medicinal Chemistry. 2006 ; 41( 3): 408-416.[citado 2024 out. 15 ] Available from: https://doi.org/10.1016/j.ejmech.2005.10.019Vancouver
Cardoso HS, Bicalho B, Genari P, Santagada V, Caliendo G, Perissutti E, Donato JL, De Nucci G. In vitro mutagenicity of anti-inflammatory parsalmide analogues PA7, PA10, and PA31 triggered by biotransformation into hydroxy derivatives [Internet]. European Journal of Medicinal Chemistry. 2006 ; 41( 3): 408-416.[citado 2024 out. 15 ] Available from: https://doi.org/10.1016/j.ejmech.2005.10.019